NCT05704985 2025-05-29Evaluating Safety and Biomarkers Using DK210 (EGFR) for Locally Advanced or Metastatic EGFR+ TumorsDEKA BiosciencesPhase 1 Active not recruiting39 enrolled
NCT00003657 2017-01-20High-dose ICE With AmifostineDana-Farber Cancer InstitutePhase 2 Completed24 enrolled